Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured
Published in Eye Care

Journal Scan / Research · February 20, 2014

Three-Year Outcomes of Individualized Ranibizumab in Diabetic Macular Edema

Ophthalmology

 

Additional Info

Ophthalmology
Three-Year Outcomes of Individualized Ranibizumab Treatment in Patients With Diabetic Macular Edema: The RESTORE Extension Study
Ophthalmology 2014 Feb 01;[EPub Ahead of Print], U Schmidt-Erfurth, GE Lang, FG Holz, RO Schlingemann, P Lanzetta, P Massin, O Gerstner, AS Bouazza, H Shen, A Osborne, P Mitchell

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading